四川雙馬(000935.SZ):預計一季度淨利潤同比增長1047%-1506%
格隆匯4月14日丨四川雙馬(000935.SZ)公佈,預計一季度歸屬於上市公司股東的淨利潤10,000萬元–14,000萬元,比上年同期增長1,047%-1,506%,扣除非經常性損益後的淨利潤9,500萬元–13,500萬元。報告期內,公司業績較上年同期有較大增長,主要是本期公司所投資的基金取得了良好的收益所致。公司在報告期內,持續挖掘潛力降本增效,同時加大投入推動技術創新、拓展新的市場,爲公司未來的穩定健康發展打下堅實基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.